Patriot Scientific Corporation Announces Smith & Nephew’s Purchase Of A Moore Microprocessor Patent™ Portfolio License

July 1, 2009 -- CARLSBAD, Calif.-- Patriot Scientific Corporation (OTC BB:PTSC) announced today that Smith & Nephew has purchased a Moore Microprocessor Patent™ (MMP) Portfolio license from The TPL Group. Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management, and joins a distinguished list of global systems manufacturers that have become MMP Licensees.

The MMP Portfolio patents cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment and automobiles which today have dozens of microprocessor-based key features and benefits.